Vicarious Surgical (RBOT) Non-Current Debt (2021 - 2022)
Vicarious Surgical's (RBOT) quarterly Non-Current Debt came in at $250000.0 in Q3 2022, down 70.1% year-on-year from $836000.0 in Q3 2021, and down 36.22% on a QoQ basis from $392000.0 in Q2 2022.
Vicarious Surgical (RBOT) Non-Current Debt (2021 - 2022) Analysis & Trends
Vicarious Surgical (RBOT) has 2 years of Non-Current Debt data on file, last reported at $250000.0 in Q3 2022.
- On a quarterly basis, Non-Current Debt fell 70.1% year-over-year to $250000.0 in Q3 2022; TTM through Sep 2022 was $250000.0, a 70.1% decrease from a year earlier, with the FY2021 full-year figure at $675000.0, changed N/A from the prior year.
- Non-Current Debt for Q3 2022 stood at $250000.0, down from $392000.0 in the prior quarter.
- Over the last five years, Non-Current Debt for RBOT reached as high as $836000.0 in Q3 2021 and fell as low as $250000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 250,000.00 |
| Jun 30, 2022 | 392,000.00 |
| Mar 31, 2022 | 534,000.00 |
| Dec 31, 2021 | 675,000.00 |
| Sep 30, 2021 | 836,000.00 |